Deputy Director and Chief Technology Officer, Division of Cancer Prevention
National Cancer Institute
Location: Rockville, Maryland
Type: Full Time
Preferred Education: MD
This position will be filled under a Title 42 excepted service appointment. Salary is competitive and will be commensurate with the experience of the candidate.
Internal Number: DCP DD CTO1
Office of the Director National Cancer Institute National Institutes of Health Department of Health and Human Services
The Person: The NCI is seeking an innovative leader to serve as its Deputy Director and Chief Technology Officer (dual role) for the Division of Cancer Prevention (DCP). The DCP (http://prevention.cancer.gov/) conducts and supports research to determine a person's risk of cancer and to find ways to reduce the risk. Research fostered by the Division focuses on translational prevention and detection, but also spans the disease process: early interventions to stop or slow the progression of cancer, and symptom management during treatment.
The Deputy Director and Chief Technology Officer (DD/CTO), DCP, serves as a senior scientific authority within the DCP and NCI for establishing the research agenda and overseeing research to identify and expand technological solutions to fundamentally improve cancer prevention and symptom management. Specifically, the DD/CTO exercises responsibility for the following:
Leads scientific discovery and research programs on technology solutions to enhance and improve cancer prevention and symptom management. Monitors research efforts and makes decisions necessary for accomplishing program goals within available resources.
Participates with the Director, DCP, and the Principal Deputy Director, DCP, in the planning, direction, implementation, and evaluation of a coordinated program of research in technological solutions to improve and enhance cancer prevention.
Provides direction and oversight for senior professional staff responsible for managing a portfolio of research on cancer prevention technologies, including (but not limited to) imaging and image analysis, ‘omics, novel molecular techniques for measuring biomarkers in biospecimens (e.g., liquid biopsies), translation of discoveries into prototype products, drug discovery and delivery, new assays, and other biomedical engineering, bioengineering, and technology developments that will enhance and lead to new discoveries in cancer prevention research.
Determines highly complex and diversified approaches to effective research and scientific achievement and recommend decisions to the Director relative to program direction, emphasis, integration, discontinuation, or augmentation of research projects, in conjunction with committed research goals, advice of outside experts, available financial and staff resources, and needed facilities.
Provides expertise, advice, guidance, leadership, and direction to program managers and staff throughout the DCP and NCI as well as in other Institutes, agencies, and research organizations regarding research efforts to develop new technologies for cancer prevention, early detection, screening, and prevention and management of symptoms and toxicities in cancer patients.
Serves as scientific advisor and consultant on the quality and merit of cancer prevention technological solutions research being performed by other major research institutions, both domestic and foreign.
Represents the DCP, NCI, and NIH in communicating scientific needs and results to diverse communities served by the NCI.
Salary/Benefits: This position will be filled under a Title 42 excepted service appointment. Salary is competitive and will be commensurate with the experience of the candidate. A recruitment or relocation bonus may be available, and relocation expenses may be paid. A full package of federal Civil Service benefits is available, including retirement, health and life insurance, long term care insurance, leave, and a Thrift Savings Plan (401K equivalent). The successful candidate may be subject to a background investigation and public financial disclosure requirements.
At the discretion of the supervisor and NIH policy, you may be eligible for workplace flexibilities, which may include remote work or telework options, and/or flexible work scheduling. These flexibilities may be requested in accordance with NIH Workplace Flexibilities guidance.
How to Apply: Applicants must submit a current curriculum vitae, bibliography, and full contact details for three references. In addition, applicants must prepare two statements: a vision statement and a statement that addresses the specific qualification requirements (please limit both statements to two pages each). NCI will begin accepting applications from October 19, 2021 through November 18, 2021. Send the application package to email@example.com.
Position Requirements: The successful candidate will have a M.D. or Ph.D. in a biomedical engineering, biomedical science, bioengineering, or biotechnology, or other relevant engineering/science discipline, with demonstrated scientific experience in technology solutions for health. Candidates with a successful program in cancer research, especially cancer prevention research, is highly desirable but not required. The candidate must be able lead, implement, and evaluate scientific discovery and research programs on technology solutions to enhance and improve cancer prevention and symptom management. As a scientific advisor, the candidate must be able to provide guidance and direction regarding research efforts to develop new technologies for cancer prevention, early detection, screening, and prevention and management of symptoms and toxicities in cancer patients. The candidate must be an experienced manager responsible for providing direction and oversight for senior professional staff who manage a portfolio of research on cancer prevention technologies. The candidate must have experience in establishing successful partnerships with a broad range of agencies and non-federal organizations. In addition, the candidate must have excellent written and oral communications skills as demonstrated through publications and presentations.
As a condition of employment, all federal employees must be fully vaccinated against COVID-19. During the onboarding process, if selected, you must provide proof of vaccination. An official job offer and continued employment is contingent on this requirement. For more information on this requirement, visit the Safer Federal Workforce page on vaccines. If you need a COVID-19 vaccine, please visit Vaccines.gov.
The Division of Cancer Prevention (DCP) conducts and supports research to determine a person's risk of cancer and to find ways to reduce the risk. This knowledge is critical to making progress against cancer because risk varies over the lifespan as genetic and epigenetic changes can transform healthy tissue into cancer.
With an overall goal to detect such changes and intervene early in the cancer process to prevent symptomatic disease and death, DCP funds and provides support to clinical and laboratory researchers, community and multidisciplinary teams, and scientific networks.